Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

In this article, we present a framework designed to evaluate the progress and impact of AI tools across various use cases in drug discovery ... 20 drugs with disease-target associations identified ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced ... on application of biology, hit discovery, target discovery,” he said.

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target ... rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...